Clinical trials: Neutrophilic Asthma
Asthma
GSK2190915 Neutrophilic Asthma Study
The purpose of this study is to investigate the effect on repeat doses of GSK2190915 in asthmatic patients with a high percentage of neutrophils in their sputum.
- Trial name
- NCT01471665
- Testing
- GSK2190915 100mg
- Where
- United Kingdom
- Volunteers
- 14 people
- Sponsor
- GlaxoSmithKline
Asthma
Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)
Evaluation of treatment in participants with mild asthma.
- Trial name
- NCT00688467
- Testing
- Navarixin
- Volunteers
- 19 people
- Sponsor
- Merck Sharp & Dohme LLC
Neutrophilic Asthma
Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)
4-Week Safety Study in Subjects with Neutrophilic Asthma
- Trial name
- NCT00632502
- Testing
- Navarixin, Rescue medication
- Volunteers
- 37 people
- Sponsor
- Merck Sharp & Dohme LLC
Asthma
Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069
Distribution of neutrophils in bronchial mucosal tissue in asthma patients before and after 4 wk treatment with AZD 5069
- Trial name
- NCT01890148
- Testing
- AZD5069
- Where
- Germany
- Volunteers
- 13 people
- Sponsor
- AstraZeneca